News in Drug Development & AI
Prof. Yaakov Nahmias is a bioengineer and innovator, whose breakthroughs ranged from the first 3D printing of cells to the first commercial human-on-chip technology. In this exciting fireside chat with…
What happens when humans become digital? This is the question that Dr. Divya Chander – a physician and neuroscientist who trained at Harvard, UCSD, UCSF and the Salk Institute –…
Are We Ready for Genetically Modified Humans?
New tools like gene editing allow humans to change nature to their liking. Jamie Metzl, author of Hacking Darwin, illustrates what’s now possible and asks how far we should go.